Research

A study released in March of more than 27,500 patients showed that Repatha cut the risk of heart attacks by 27 per cent and stroke…

Opdivo, or nivolumab is a PD-1 inhibitor, designed to help the body’s own immune system fend off cancer by blocking a protein…

Cancer drugs that cause tumours to shrink are considered likely to confer a meaningful clinical benefit, such as survival

The new study allows prevention measures to be targeted at those individuals most at risk of developing IE

Herceptin and other complex medicines called biologics are made from living cells, making them difficult to copy with precision

Dr Sanjeev Saxena, Founder and CEO, POC Medical Systems in an interaction with Viveka Roychowdhury, gives information about low…

Johnson & Johnson (J&J) recently entered into a partnership with the Institute of Microbial Technology (IMTECH), part of…

According to European Association for the Study of Obesity (EASO), healthcare systems should be adapted and professionals should…

Dr Mayur Yergeri, Associate Dean and Professor, SPPSPTM, SVKM’s NMIMS-Deemed to be University, has developed a new series of…

Taher Abbasi, COO and Co-Founder, Cellworks, shares how precision medicine is gaining momentum in healthcare and how simulation…